Dexeus Mujer implements NIPT universally as a screening method to improve the sensitivity of chromosomal abnormality detection
Dexeus Mujer has updated its prenatal aneuploidy screening strategy by universally implementing Non-Invasive Prenatal Testing (NIPT). As is well known, NIPT offers 99% sensitivity for the most common chromosomal abnormalities, which is significantly higher than that provided by traditional screening methods.
